These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1690517)

  • 1. Effects of a kinin antagonist on renal function in rats.
    Nakagawa M; Stewart JM; Vavrek RJ; Nasjletti A
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F643-8. PubMed ID: 1690517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system.
    Filep J; Rigter B; Földes-Filep E
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
    Johnston CI; Clappison BH; Anderson WP; Yasujima M
    Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat.
    Jaffa AA; Vio CP; Silva RH; Vavrek RJ; Stewart JM; Rust PF; Mayfield RK
    J Clin Invest; 1992 May; 89(5):1460-8. PubMed ID: 1373739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo.
    Ura N; Carretero OA; Erdös EG
    Kidney Int; 1987 Oct; 32(4):507-13. PubMed ID: 2828746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of kinins and angiotensin II on the regulation of papillary blood flow.
    Roman RJ; Kaldunski ML; Scicli AG; Carretero OA
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F690-8. PubMed ID: 2845811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
    Seto S; Kher V; Scicli AG; Beierwaltes WH; Carretero OA
    Hypertension; 1983; 5(6):893-9. PubMed ID: 6197374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of aprotinin, a kallikrein inhibitor in rats in saline diuresis.
    Kauker ML
    Proc Soc Exp Biol Med; 1985 Feb; 178(2):222-6. PubMed ID: 2578672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of modulation of renal kallikrein-kinin system in the nephrotic syndrome.
    Hutchison FN; Martin VI
    Am J Physiol; 1990 May; 258(5 Pt 2):F1237-44. PubMed ID: 1692447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH; Anderson WP; Johnston CI
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
    Fenoy FJ; Scicli G; Carretero O; Roman RJ
    Hypertension; 1991 Jun; 17(6 Pt 2):1038-44. PubMed ID: 1646165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aprotinin-induced kallikrein inhibition on the cardiovascular and renal action of captopril in diuretic-treated dogs.
    Vemulapalli S; Chiu PJ
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):109-23. PubMed ID: 6191727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function as affected by inhibitors of kininase II and of neutral endopeptidase 24.11 in rats with and without desoxycorticosterone pretreatment.
    Nakagawa M; Nasjletti A
    Adv Exp Med Biol; 1989; 247B():495-9. PubMed ID: 2692417
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of the renin-angiotensin-aldosterone and kallikrein-kinin systems in the control of fluid and electrolyte metabolism, renal function, and arterial blood pressure.
    McCaa RE
    Clin Exp Hypertens A; 1982; 4(9-10):1593-611. PubMed ID: 6754146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension.
    Cachofeiro V; Sakakibara T; Nasjletti A
    Hypertension; 1992 Feb; 19(2):138-45. PubMed ID: 1737647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of Fab fragments of kinin antibodies on deoxycorticosterone acetate-salt-treated rats.
    Tomiyama H; Scicli AG; Scicli GM; Carretero OA
    Hypertension; 1990 Jun; 15(6 Pt 2):761-6. PubMed ID: 2351428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.
    Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
    Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal hyperfiltration states: relationship to kallikrein and kinins.
    Mayfield RK; Jaffa AA; Edmundson AW; Harvey JN
    Agents Actions Suppl; 1992; 38 ( Pt 3)():142-8. PubMed ID: 1281377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
    Chen K; Zhang X; Dunham EW; Zimmerman BG
    Hypertension; 1996 Jan; 27(1):85-9. PubMed ID: 8591894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.